This assay can distinguish FSHD from healthy controls, differentiate FSHD1 from FSHD2, does not require HMW genomic DNA or PFGE, and can be performed on either cultured cells, tissue, blood, or saliva samples. The gene discussed is SMCHD1; the disease is facioscapulohumeral muscular dystrophy.